VC-Backed Glaukos Beats Expectations With $108M IPO
California-based, venture capital-backed Glaukos Corp. raised $108 million in its initial public offering Thursday, beating expectations and pricing its shares at $18 apiece as the implantable glaucoma treatment developer looks to...To view the full article, register now.
Already a subscriber? Click here to view full article